Stem Holdings Stock Current Valuation
Valuation analysis of Stem Holdings helps investors to measure Stem Holdings' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Stem Holdings' price fluctuation is out of control at this time. Calculation of the real value of Stem Holdings is based on 3 months time horizon. Increasing Stem Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Stem otc stock is determined by what a typical buyer is willing to pay for full or partial control of Stem Holdings. Since Stem Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stem OTC Stock. However, Stem Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The intrinsic value of Stem Holdings' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Stem Holdings' stock price.
Estimating the potential upside or downside of Stem Holdings helps investors to forecast how Stem otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stem Holdings more accurately as focusing exclusively on Stem Holdings' fundamentals will not take into account other important factors: Stem Holdings OTC Stock Current Valuation Analysis
Stem Holdings' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Stem Holdings Current Valuation | 13.19 M |
Most of Stem Holdings' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stem Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Stem Holdings has a Current Valuation of 13.19 M. This is 99.91% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.92% higher than that of the company.
Stem Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stem Holdings' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Stem Holdings could also be used in its relative valuation, which is a method of valuing Stem Holdings by comparing valuation metrics of similar companies.Stem Holdings is currently under evaluation in current valuation category among its peers.
Stem Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.18 | |||
| Profit Margin | (1.05) % | |||
| Operating Margin | (0.75) % | |||
| Current Valuation | 13.19 M | |||
| Shares Outstanding | 238.5 M | |||
| Shares Owned By Insiders | 1.84 % | |||
| Shares Owned By Institutions | 0.12 % | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 16.56 M | |||
| Gross Profit | 2.12 M | |||
| EBITDA | (13.47 M) | |||
| Net Income | (17.37 M) | |||
| Cash And Equivalents | 3.4 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.23 M | |||
| Debt To Equity | 0.43 % | |||
| Current Ratio | 1.25 X | |||
| Book Value Per Share | 0.07 X | |||
| Cash Flow From Operations | (6.47 M) | |||
| Earnings Per Share | (0.27) X | |||
| Target Price | 26.97 | |||
| Number Of Employees | 150 | |||
| Beta | 0.95 | |||
| Market Capitalization | 4.77 M | |||
| Total Asset | 30.98 M | |||
| Z Score | 1.8 | |||
| Net Asset | 30.98 M |
About Stem Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stem Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stem Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stem Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Stem OTC Stock
Stem Holdings financial ratios help investors to determine whether Stem OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Holdings security.